Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A better option for mild to moderate depression?

2.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

3.

The need for more Latinx participants in Alzheimer's trials is urgent.

4.

An ultrasound breast patch with conformability might help with early breast cancer detection.

5.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot